B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Genistein

An isoflavonoid derived from soy products. It inhibits PROTEIN-TYROSINE KINASE and topoisomerase-II (DNA TOPOISOMERASES, TYPE II); activity and is used as an antineoplastic and antitumor agent. Experimentally, it has been shown to induce G2 PHASE arrest in human and murine cell lines and inhibits PROTEIN-TYROSINE KINASE.

300 PubMed studies analyzed · 3 RCTs · Evidence Score: 43.2

Research Domains

Genistein has been studied across 23 research domains including 🔬 Oncology, 🧬 Hormones, 🔬 Inflammation, 🫁 Liver & Detox, 🦴 Bone & Joint. The primary research focus is 🔬 Oncology with 29% of studies addressing this area.

Loading evidence profile...

This evidence profile for Genistein is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.